This price is what Terry Fern paid in a off market transaction. DateDirectorTypeAmountPriceValueNotes14/07/21Terrence FernBuy+39,318,011$0.001$45,653Off-market trade
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%